About Us: Company at a Glance


Our Mission


To provide our customers with the finest, high-quality service in the highly regulated clinical biomarker industry.


Our Vision


To predict the response to the high value medicines of tomorrow.

Our Values


Founded in Kassel, Germany in 2005 by Dr. Thomas Henkel, Prof. Josef Rüschoff and Prof. Reinhard Büttner.


80 and growing in three divisions.


+ 16 senior consulting clinical pathologists in Kassel, Cologne and Göttingen, Germany


Partnerships Pathologie Nordhessen, Kassel, Germany University of Cologne, Cologne, Germany University of Göttingen, Göttingen, Germany

Companion Diagnostics


· The first co-development of companion diagnostics for Roche COBAS and B-Raf together with Genentech/Roche drug Zelboraf in a prospective clinical trial.

· HercepTest™ for Herceptin™ for Gastric Cancer in a prospective clinical trial.

Quality Assurance

Audited annually since 2005 by FDA, Pharma PDQA and Biotech QA Collaborations With more than 30 industry leading pharmaceutical, biotech and diagnostic companies in Europe and United State.

Reference Laboratory

For Europe, Latin America and the Middle East.


High impact publications of supported trials in The Lancet, New England Journal of Medicine, Journal of Clinical Oncology etc.


Prof. Dr. med. Josef Rüschoff: International Herceptin Pathology Advisory Board.Prof. Dr. med. Reinhard Büttner: Member of the German Academy for Sciences.

Turn-around Time

As low as 24 hours for clinical tissue biomarker analysis

Global Clinical Trials

Reference laboratory for global clinical trials. Analysis of more than 60,000 patients in 100 clinical trials pertaining to breast, Agastric, lung and skin cancers in more than 1000 sites worldwide